有机化学人才网 | 最新人才 | 最新职位 | 技术交易 | 药物合成 |
   
全站搜索: |
  您当前位置:网站首页 >> 药物合成路线图解
 

药物详细合成路线

Name Cabergoline;CG-101;FCE-21336;Cabaseril;Sogilen;Cabaser;Dostinex
Chemical Name 1-[(6-Allylergolin-8beta-yl)carbonyl]-1-[3-(dimethylamino)propyl]-3-ethylurea
      (6aR,9R,10aR)-7-Allyl-N-[3-(dimethylamino)propyl]-N-(N-ethylcarbamoyl)-4,6,6a,7,8,9,10,10a-octahydroindolo[4,3-fg]quinoline-9-carboxamide
CAS 81409-90-7
Related CAS
Formula C26H37N5O2
Structure
Formula Weight 451.61709
Stage 上市-1993
Company Pfizer (Originator), National Institute on Drug Abuse (Not Determined), Paladin (Marketer), Kissei (Licensee)
Activity/Mechanism Antiparkinsonian Drugs, ENDOCRINE DRUGS, Extrapyramidal Disorders, Treatment of, NEUROLOGIC DRUGS, Pituitary Disorder Therapy, Treatment of Acromegaly, Treatment of Cocaine Dependency, Treatment of Growth Hormone Secretion Disorders, Treatment of Hyperprolactinemia, TREATMENT OF POISONING, DRUG ABUSE & DEPENDENCY, Treatment of Substance Dependency, Dopamine D2 Agonists, Prolactin Secretion Inhibitors
Syn. Route 3
Route 1
the synthesis of tritiated cabergoline by two similar routes has been described:1) the acylation of 6-nor-dihydrolysergic acid methyl ester (i) with propargyl bromide yields the corresponding 6-propargyl derivative (ii), which is hydrogenated with tritium gas over pd/c in the presence of quinoline to give the ditritiated 6-allyl derivative (iii). this compound is treated with 3-(dimethylamino)propylamine at 120 c, yielding the amide (iv), which is finally treated with ethyl isocyanate.2) the reaction of the propargyl derivative (ii) with 3-(dimethylamino)propylamine as before gives the amide (v). the reaction of (v) with ethyl isocyanate gives compound (vi), which is then hydrogenated with tritium as before.
List of intermediates No.
1-(2-chloroethyl)azepane
ethyl 2-(1-piperazinyl)phenyl ether; 1-(2-ethoxyphenyl)piperazine (i)
ethyl 3-cyclohexylpropanoate (ii)
4-([[amino(imino)methyl]amino]methyl)cyclohexanecarboxylic acid (iv)
benzyl salicylate (v)
benzyl 2-([[4-([[amino(imino)methyl]amino]methyl)cyclohexyl]carbonyl]oxy)benzoate (vi)
(r,r)-cyclohexane-1,2-diamine dichloro platinum complex (iii)
methyl 2-butyl-4-oxo-3,4-dihydro-6-quinazolinecarboxylate
Reference 1:
    mantegani, s.; brambilla, e.; ermoli, a.; fontana, e.; angiuli, p.; vicario, g.p.; syntheses of tritium and carbon-14 labelled n-(3-dimethyl aminopropyl)-n-(ethylaminocarbonyl)-6-(2-propenyl)ergoline-8beta-carboxamide (cabergoline), a potent long lasting prolactin lowering agent. j label compd radiopharm 1991, 29, 5, 519.

Route 2
the synthesis of [14c]-cabergoline has also been described:the reaction of 6-allylergoline-8beta-carboxylic acid methyl ester (i) with hydrazine in refluxing methanol gives the hydrazide (ii), which by reaction with nano2-hcl in water is converted to the amine (iii). the reaction of (iii) again with nano2-hcl in water, followed by reaction with sncl2, affords the chloro derivative (iv), which is condensed with [14c]-cnk in refluxing ethanol-water yielding the nitrile (v). hydrolysis of (v) with naoh in refluxing ethanol affords the acid (vi), which is finally condensed with n-ethyl-n-[3-(dimethylamino)propyl]carbodiimide in dmf.
List of intermediates No.
(r,r)-cyclohexane-1,2-diamine dichloro platinum complex (i)
6-nitro-2,3-dihydro-1h-inden-5-yl phenyl ether; 5-nitro-6-phenoxyindane (ii)
n,n-dimethyl-n-[(5-nitro-6-phenoxy-2,3-dihydro-1h-inden-1-ylidene)methyl]amine; n,n-dimethyl(5-nitro-6-phenoxy-2,3-dihydro-1h-inden-1-ylidene)methanamine (iii)
5-nitro-6-phenoxy-1-indanone (iv)
5-amino-6-phenoxy-1-indanone (v)
6-phenoxy-2,3-dihydro-1h-inden-5-ylamine; 6-phenoxy-5-indanamine (vi)
2-butyl-6-(1-hydroxy-1-methylethyl)-4(3h)-quinazolinone (vi)
Reference 1:
    mantegani, s.; brambilla, e.; ermoli, a.; fontana, e.; angiuli, p.; vicario, g.p.; syntheses of tritium and carbon-14 labelled n-(3-dimethyl aminopropyl)-n-(ethylaminocarbonyl)-6-(2-propenyl)ergoline-8beta-carboxamide (cabergoline), a potent long lasting prolactin lowering agent. j label compd radiopharm 1991, 29, 5, 519.

Route 3
this compound can be obtained by two differents ways:1) by condensation of 6-allyl-n-[3-(dimethylamino)propyl]ergolin-8-beta-caboxamide (i) with ethyl isocyanate (ii) in refluxing toluene.2) by condensation of 6-allylergolin-8-beta-carboxylic acid (iii) with n-ethyl-n-[3-(dimethylamino)propyl]carbodiimide (iv) in refluxing thf.
List of intermediates No.
4-([[amino(imino)methyl]amino]methyl)cyclohexanecarboxylic acid (i)
methyl (z)-7-[(2r,4r,5s)-4-(hydroxymethyl)-2-methyl-1,3-dioxan-5-yl]-5-heptenoate (iv)
methyl 2-butyl-4-oxo-3,4-dihydro-6-quinazolinecarboxylate (ii)
2-butyl-6-(1-hydroxy-1-methylethyl)-4(3h)-quinazolinone (iii)
Reference 1:
    temperilli, a.; bernardi, l.; brambilla, e. (pharmacia corp.); regiospecific process for the preparation of ergoline derivatives. be 0894060; jp 58038282 .
Reference 2:
    salvati, p.; et al. (pharmacia & upjohn spa); composés dérivés de lergoline, procédé pour les préparer et leur usage comme médicaments. de 3112861; fr 2479829 .
Reference 3:
    serradell, m.n.; azccheo, t.; castaner, j.; castaner, r.m.; giudici, d.; cabergoline. drugs fut 1987, 12, 9, 842.

来源:药化网

作者:药化小编

摘要:本文合成路线介绍的是药物中文名卡麦角林;英文名Cabergoline;CG-101;FCE-21336;Cabaseril;Sogilen;Cabaser;Dostinex;CAS[81409-90-7]

 
推荐VIP企业
无锡景耀生物科技有限公司
杭州卢普生物科技有限公司
宁波赛伦化工有限公司
苏州昊赛生物科技有限公司
北京嘉盛扬医药科技有限公司
上海泽涵生物医药科技有限公司
河北固安三利化工公司
郑州凯普瑞生物技术有限公司
上海药谷药业有限公司
兰州康寓信生物科技有限公司
湖北朗昕生化药业有限公司
武汉福鑫化工有限公司
嘉兴市英南化工有限公司
苏州迪飞医药科技有限公司
北京富安凯科技有限公司
上海盛中医药化工有限公司
连云港天和化学有限公司
南京晨瑞医药科技有限公司
南京苏如化工有限公司
常州瑞盛化工有限公司
热门文章
罗氏向 FDA 递交 Kadc
前列腺癌药物苯扎鲁胺达到 AR
欧盟批准武田霍奇金淋巴瘤药物
赛诺菲砍掉 38 个研发项目,
AZ 抗病毒药物 MEDI88
赛诺菲 Darzalex 竞争
默沙东向 FDA 提交两款抗菌
两降一涨!蓝丰/国发/新奥发布
华北地区醋酸价格
河南地区醋酸价格暂稳
华北地区丁二烯市场观望为主
华东地区BDO市场商谈整理
山东地区醋酸价格
陕西地区醋酸价格下调
江苏地区醋酸价格下调
PTA止跌在眼前
华东苯酐市场行情
华东地区丁二烯市场弱势盘整
浙江地区二氯甲烷价格暂稳
山东地区木薯酒精市场稳定
 友情链接
有机化学人才网  
首页 | 广告服务 | 建站服务 | 关于我们 | 联系我们 | 版权声明